Combination Of Tern-101, A Farnesoid X Receptor Agonist, And Tern-501, A Selective Agonist Of Thyroid Hormone Receptor Beta, Reduces Activation Of Inflammatory And Fibrotic Gene Pathways In A Mouse Model Of Non-Alcoholic Steatohepatitis